Vaccine Overview for
About the Moderna COVID-19 Vaccine
The Moderna COVID‑19 Vaccine is an unapproved vaccine that has been authorized for emergency use by the FDA for active immunization to prevent COVID‑19 in individuals 18 years of age and older. The vaccine was developed by Moderna, a biotechnology company that has focused on mRNA technology since 2010, and is currently being studied in a large Phase 3 trial.Learn more about the Moderna COVID‑19 Vaccine
Storage & Handling
The Moderna COVID-19 Vaccine multiple‑dose vials are stored frozen between -25º to -15ºC (-13º to 5ºF). Store in the original carton to protect from light. Do not store on dry ice or below -40ºC (-40ºF).
Vials can be stored refrigerated between 2° to 8°C (36° to 46°F) for up to 30 days prior to first use.How to properly store and handle
Dosing & Administration
The Moderna COVID‑19 Vaccine is administered by intramuscular injection as a series of two doses (0.5 mL each) 1 month apart.Get full dosing details
Clinical Trial Data
The Moderna COVID‑19 Vaccine was evaluated in an ongoing Phase 3 randomized, placebo‑controlled, observer‑blind clinical trial conducted in the United States.See clinical trial data
Who Has CDC Prioritized for Vaccination?
In response to the COVID‑19 pandemic, the Advisory Committee on Immunization Practices (ACIP) has made recommendations on vaccine prioritization. While the supply is limited, vaccination will be available to a limited number of people. Criteria for vaccination and designated vaccination sites may expand as vaccine supply increases. States are making the ultimate determination about who will receive the vaccine first.Learn more about prioritization